Regulus Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) ...Middle East

PR Newswire - News
Regulus Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
SAN DIEGO, Jan. 13, 2023 /PRNewswire/ -- Regulus Therapeutics Inc. (Nasdaq: RGLS), a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs (the "Company" or "Regulus"), today announced the grant of an inducement stock option to...

Hence then, the article about regulus reports inducement grant under nasdaq listing rule 5635 c 4 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Regulus Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) )

Apple Storegoogle play

Last updated :

Also on site :